[Pillars of therapy of chronic obstructive bronchitis].
While bronchial asthma is defined on the basis of pulmonary function, emphysema has a patho-anatomic substrate. Chronic bronchitis on the other hand is defined clinically: productive cough of three months duration per year occurring in two successive years. Complete abstinence of smoking is a prerequisite for a meaningful anti-obstructive therapy. Beta-2-adrenergic stimulation and corticosteroids represent the treatment of choice. Beta-2-agonists are effectively complemented by anticholinergic drugs. Oral or parenteral corticosteroids should be used liberally for exacerbations. For prolonged treatment topical steroids are prescribed exclusively in order to prevent systemic side effects. The type of inhalation therapy (electric nebulizer, aerosol spray, insufflator) has to be adapted to the individual patient. Correct application of inhalation-technique is important. Topical steroids should be administered by means of a spacer chamber. Physical therapy is the most important adjuvant treatment. Selective respiration-training, a correction of breath-technique and autogenic bronchial drainage manoeuvres have to be learned in the setting of a rehabilitation program and are controlled frequently by the treating physician. The integration of all these measures into a treatment and rehabilitation plan is facilitated in a specialized clinic.
Karrer
W
W
D000280:Administration, Inhalation; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D000318:Adrenergic beta-Agonists / Q000008:administration & dosage; D001991:Bronchitis / Q000628:therapy*; D002908:Chronic Disease; D003131:Combined Modality Therapy; D006801:Humans; D010276:Parasympatholytics / Q000008:administration & dosage; D012907:Smoking / Q000009:adverse effects; D000074606:Smoking Prevention
D000305:Adrenal Cortex Hormones; D000318:Adrenergic beta-Agonists; D010276:Parasympatholytics
Grundpfeiler der Therapie der chronischen obstruktiven Bronchitis.